लोड हो रहा है...
BH4 domain of Bcl-2 as a novel target for cancer therapy
Overexpression of B cell lymphoma 2 (Bcl-2) proteins is associated with therapy resistance in various human cancers. Traditional approaches target the Bcl-2 homology (BH)3 domain of Bcl-2; however, the BH4 domain represents a superior therapeutic target in light of its unique structure and crucial i...
में बचाया:
| में प्रकाशित: | Drug Discov Today |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4882289/ https://ncbi.nlm.nih.gov/pubmed/26631752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2015.11.008 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|